[{"address1": "3710 \u2013 33rd Street NW", "city": "Alberta Beach", "state": "AB", "zip": "T2L 2M1", "country": "Canada", "phone": "(403) 455-7727", "website": "https://www.xortx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, pre-diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, a program to treat acute kidney injury (AKI) associated with respiratory virus infection and associated health consequences; and XRX-225, a program for treatment of type 2 diabetic nephropathy. It has a collaboration and license agreements with the Icahn School of Medicine; and a license agreement with the University of Florida Research Foundation, Inc. The company is based in Alberta Beach, Canada.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Dr. Allen Warren Davidoff Ph.D.", "age": 63, "title": "Founder, CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 337794, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James Neville Fairbairn C.A., C.P.A., ICD.D", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 76201, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Haworth M.D., MRCP", "age": 73, "title": "Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2023, "totalPay": 200229, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stacy  Evans M.B.A., M.D.", "age": 49, "title": "Chief Business Officer", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 280000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nick  Rigopoulos", "title": "Director of Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Sans M.B.A., Ph.D.", "age": 53, "title": "Director of Corporate Development", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  MacDonald Ph.D.", "age": 59, "title": "Consultant of Clinical Operations", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Charlotte  May", "title": "Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.6, "open": 2.63, "dayLow": 2.57, "dayHigh": 2.63, "regularMarketPreviousClose": 2.6, "regularMarketOpen": 2.63, "regularMarketDayLow": 2.57, "regularMarketDayHigh": 2.63, "forwardPE": -1.5357143, "volume": 9787, "regularMarketVolume": 9787, "averageVolume": 51259, "averageVolume10days": 15890, "averageDailyVolume10Day": 15890, "marketCap": 7491184, "fiftyTwoWeekLow": 1.98, "fiftyTwoWeekHigh": 67.716, "fiftyDayAverage": 3.21076, "twoHundredDayAverage": 15.36857, "currency": "USD", "enterpriseValue": 2446108, "floatShares": 2206188, "sharesOutstanding": 2903560, "sharesShort": 8803, "sharesShortPriorMonth": 21103, "sharesShortPreviousMonthDate": 1711584000, "dateShortInterest": 1714435200, "sharesPercentSharesOut": 0.003, "heldPercentInsiders": 0.04822, "heldPercentInstitutions": 0.09329, "shortRatio": 0.49, "shortPercentOfFloat": 0.0031, "impliedSharesOutstanding": 3213850, "bookValue": 1.025, "priceToBook": 2.5170732, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -3344966, "trailingEps": -1.38, "forwardEps": -1.68, "lastSplitFactor": "1:9", "lastSplitDate": 1699920000, "enterpriseToEbitda": -0.634, "52WeekChange": -0.9563673, "SandP52WeekChange": 0.26137078, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "XRTX", "underlyingSymbol": "XRTX", "shortName": "XORTX Therapeutics Inc.", "longName": "XORTX Therapeutics Inc.", "firstTradeDateEpochUtc": 1632403800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ccf511eb-7240-3e07-af90-4d0cc6586c46", "messageBoardId": "finmb_259860883", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.58, "targetHighPrice": 14.01, "targetLowPrice": 10.3, "targetMeanPrice": 12.16, "targetMedianPrice": 12.16, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 3835440, "totalCashPerShare": 1.579, "ebitda": -3858837, "totalDebt": 14037, "quickRatio": 11.341, "currentRatio": 13.676, "debtToEquity": 0.563, "returnOnAssets": -0.31002, "returnOnEquity": -0.57921004, "freeCashflow": -2960390, "operatingCashflow": -5401830, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-27"}]